Management of painful diabetic polyneuropathy Expert-consensus, SFD 2010;Prise en charge de la polyneuropathie diabétique douloureuse: Référentiel de la Société francophone du diabète (SFD) 2010

Medecine des Maladies Metaboliques

Volumn 5, Issue 2, 2011, Pages 208-222

  Hartemann, Agnès ^a   Attal, Nadine ^b   Bouhassira, Didier ^b   Dumont, Isabelle ^c   Gin, Henri ^d   Jeanne, Sandrine ^e   Said, Gérard ^f   Richard, Jean Louis ^g  

^a SORBONNE UNIVERSITÉ   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c Centre Multidisciplinaire du Pied de Ransart   (Belgium)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e CENTRE HOSPITALIER LAENNEC   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g NÎMES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONSENSUS; DIABETIC NEUROPATHY; NEUROPATHIC PAIN;

EID: 79960270478     PISSN: 19572557     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1957-2557(11)70227-9     Document Type: Article

References (137)

1. Tesfaye S, Kempler P. Painful diabetic neuropathy. Diabetologia 2005 ; 48 : 805-7. (Pubitemid 40767970)
2. Veves A, Manes C, Murray HJ, et al. Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care 1993 ; 16 : 1187-9. (Pubitemid 23215408)
3. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy : epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000 ; 47 : 123-8. (Pubitemid 30009719)
4. Gordois A, Scuffham P, Shearer A, et al. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 2003 ; 26 : 1790-5. (Pubitemid 36929121)
5. Partanen J, Niskanen L, Lehtinen J, et al. Natural history of peripheral neuropathy in patients with non-insulin dependent diabetes mellitus. N Engl J Med 1995 ; 333 : 89-94.
6. Harris MI, Eastman R, Cowie C. Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population. Diabetes Care 1993 ; 16 : 1446-52. (Pubitemid 23312532)
7. Ziegler D, Gries FA, Sperer M, Lessmann F. The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. J Diabetes Complications 1992 ;6:49-57. (Pubitemid 23034751)
8. Boulton AJM, Knight G, Drury J, Ward JD. The prevalence of symptomatic diabetic neuropathy in an insulin-treated population. Diabetes Care 1985 ; 8 : 125-8. (Pubitemid 15044008)
9. Ziegler D, Rathmann W, Dickhaus T, et al. ; KORA Study Group. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance : the MONICA/KORA Augsburg Surveys S2 and S3. Pain Med 2009 ; 10 : 393-400.
10. Daousi C, MacFarlane IA, Woodward A, et al. Chronic painful peripheral neuropathy in an urban community : a controlled comparison of people with and without diabetes. Diabet Med 2004 ; 21 : 976-82. (Pubitemid 39215316)
11. Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006 ; 29 : 1518-22. (Pubitemid 44127574)
12. Van Acker K, Bouhassira D, De Bacquer D, et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab 2009 ; 35 : 206-13.
13. Paisley AN, Abbott CA, van Schie CH, Boulton AJ. A comparison of the Neuropen against standard quantitative sensory-threshold measures for assessing peripheral nerve function. Diabet Med 2002 ; 19 : 400-5. (Pubitemid 34534215)
14. Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005 ; 114 : 29-36. (Pubitemid 40279084)
15. Wu EQ, Borton J, Said G, et al. Estimated prevalence of peripheral neuropathy and associated pain in adults with diabetes in France. Curr Med Res Opin 2007 ; 23 : 2035-42. (Pubitemid 350246591)
16. Ziegler D. Painful diabetic neuropathy : treatment and future aspects. Diabetes Metab Res Rev 2008 ; 24
17. Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life : review and implications. Neurology 2007 ; 68 : 1178-82. (Pubitemid 46608464)
18. Benbow SJ, Wallymahmed ME, MacFarlane IA. Diabetic peripheral neuropathy and quality of life. QJM 1998 ; 91 : 733-7. (Pubitemid 28508618)
19. Zelman DC, Brandenburg NA, Gore M. Sleep impairment in patients with painful diabetic peripheral neuropathy. Clin J Pain 2006 ; 22 : 681-5. (Pubitemid 44434950)
20. Tölle T, Xu X, Sadosky AB. Painful diabetic neuropathy : a cross-sectional survey of health state impairment and treatment patterns. J Diabetes Complications 2006 ; 20:26-33.
21. Barrett AM, Lucero MA, Le T, et al. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain : a review. Pain Med 2007 ; 8 (Suppl. 2) : S50-62. (Pubitemid 47288511)
22. Gore M, Brandenburg NA, Hoffman DL, et al. Burden of illness in painful diabetic peripheral neuropathy : the patients perspectives. J Pain 2006 ; 7 : 892-900. (Pubitemid 44854739)
23. Argoff CE, Cole BE, Fishbain DA, Irving GA. Diabetic peripheral neuropathic pain : clinical and quality-of-life issues. Mayo Clin Proc 2006 ; 81 (Suppl) : S3-11.
24. Boulton AJM, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care 2004 ; 1458-86. (Pubitemid 38680000)
25. Sorensen L, Molyneaux L, Yue DK. Insensate versus painful diabetic neuropathy : the effects of height, gender, ethnicity and glycaemic control. Diabetes Res Clin Pract 2002 ; 57 : 45-51. (Pubitemid 34463019)
26. Pirart J. Diabetes mellitus and its degenerative complications : a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1978 ; 1 : 168-88. (Pubitemid 9171570)
27. Robinson LR, Stolov WC, Rubner DE, et al. Height is an independent risk factor for neuropathy in diabetic men. Diabetes Res Clin Pract 1992 ; 16 : 97-102.
28. Adler AI, Boyko EJ, Ahroni JH, et al. Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 1997 ; 20 : 1162-7. (Pubitemid 27274282)
29. Sumner CJ, Sheth S, Griffin JW, et al. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003 ; 60 : 108-11. (Pubitemid 36070653)
30. Franklin GM, Kahn LB, Baxter J, et al. Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study. Am J Epidemiol 1990 ; 131 : 633-43. (Pubitemid 20137231)
31. Novella SP, Inzucchi SE, Goldstein JM. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 2001 ; 24 : 1229-31. (Pubitemid 32762153)
32. Singleton JR, Smith AG, Bromberg MB. Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 2001 ; 24 : 1225-8. (Pubitemid 32762152)
33. Putz Z, Tabak AG, Toth N, et al. Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance. Diabetes Care 2009 ; 32 : 181-3.
34. Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors : the EURODIAB IDDM Complications Study. Diabetologia 1996 ; 39 : 1377-84. (Pubitemid 26356070)
35. Elliott J, Tesfaye S, Chaturvedi N, et al. EURODIAB Prospective Complications Study Group. Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors. Diabetes Care 2009 ; 32 : 1896-900.
36. Archer SC, Watkins PJ, Thomas PK, et al. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry 1983 ; 46 : 491-9. (Pubitemid 13099694)
37. Boulton AJM, Vinik AI, Arezzo JC, et al. ; American Diabetes Association. Diabetic neuropathies : a statement by the American Diabetes Association. Diabetes Care 2005 ; 28 : 956-62. (Pubitemid 40434506)
38. Ziegler D. Painful diabetic neuropathy : advantage of novel drugs over old drugs ? Diabetes Care 2009 ; 32 (Suppl. 2) : S414-9.
39. Ellenberg M. Diabetic neuropathy precipitating after institution of diabetic control. Am J Med Sci 1958 ; 236 : 446-71.
40. Gemignani F. Acute painful diabetic neuropathy induced by strict glycemic control ("insulin neuritis") : the old enigma is still unsolved. Biomed Pharmacother 2009 ; 63 : 249-50.
41. Llewelyn JG, Thomas PK, Fonseca V, et al. Acute painful diabetic neuropathy precipitated by strict glycaemic control. Acta Neuropathol 1986 ; 72 : 157-63. (Pubitemid 17010790)
42. Tesfaye S, Malik R, Harris N, et al. Arteriovenous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia 1996 ; 39 : 329-35. (Pubitemid 26066803)
43. Ellenberg M. Diabetic neuropathic cachexia. Diabetes 1974 ; 23 : 418-23.
44. Steel JM, Young RJ, Lloyd GG, Clarke BF. Clinically apparent eating disorders in young diabetic women : associations with painful neuropathy and other complications. Br Med J (Clin Res Ed) 1987 ; 294 : 859-62. (Pubitemid 17046380)
45. Sadosky A, McDermott AM, Brandenburg NA, Strauss M. A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Pract 2008 ; 8:45-56.
46. Marchettini P, Lacerenza M, Mauri E, Marangoni C. Painful peripheral neuropathies. Curr Neuropharmacol 2006 ; 4 : 175-81.
47. Krishnan ST, Rayman G. The LDIflare : a novel test for C-fiber function demonstrates early neuropathy in type 2 diabetes. Diabetes Care 2004 ; 27 : 2930-5. (Pubitemid 39565061)
48. Quattrini C, Tavakoli M, Jeziorska M, et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 2007 ; 56 : 2148-54. (Pubitemid 47195833)
49. Said G, Baudoin D, Toyooka K. Sensory loss, pains, motor deficit and axonal regeneration in length-dependent diabetic polyneuropathy. J Neurol 2008 ; 255 : 1693-702.
50. Sorensen L, Molyneaux L, Yue DK. The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care 2006 ; 29 : 883-7. (Pubitemid 44115311)
51. Ørstavik K, Namer B, Schmidt R, et al. Abnormal function of C-fibers in patients with diabetic neuropathy. J Neurosci 2006 ; 26 : 11287-94.
52. Waxman SG. Neurobiology : a channel sets the gain on pain. Nature 2006 ; 444 : 831-2. (Pubitemid 46024984)
53. Dib-Hajj SD, Yang Y, Waxman SG. Genetics and molecular pathophysiology of Na (v) 1.7-related pain syndromes. Adv Genet 2008 ; 63 : 85-110.
54. Lunetta M, Le Moli R, Grasso G, Sangiorgio L. A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy. Diabetes Res Clin Pract 1998 ; 39 : 165-72. (Pubitemid 28255296)
55. Devigili G, Tugnoli V, Penza P, et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 2008 ; 131 : 1912-25. (Pubitemid 351957452)
56. Bennett MI, Smith BH, Torrance N, Lee AJ. Can pain can be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians. Pain 2006 ; 122 : 289-94. (Pubitemid 43729469)
57. Bennett MI, Attal N, Backonja MM, et al. Using screening tools to identify neuropathic pain. Pain 2007 ; 127 : 199-203. (Pubitemid 46084881)
58. Dworkin RH, Jensen MP, Gammaitoni AR, et al. Symptom profiles differ in patients with neuropathic versus non-neuropathic pain. J Pain 2007 ; 8 : 118-26 Erratum in : J Pain 2007 ; 8 : 531]. (Pubitemid 46186157)
59. Fishbain DA, Lewis JE, Cutler R, et al. Can the neuropathic pain scale discriminate between non-neuropathic and neuropathic pain? Pain Med 2008 ; 9 : 149-60. (Pubitemid 351285409)
60. Daousi C, Benbow SJ, Woodward A, MacFarlane IA. The natural history of chronic painful peripheral neuropathy in a community diabetes population. Diabet Med 2006 ; 23 : 1021-4. (Pubitemid 44257948)
61. Crawford B, Bouhassira D, Wong A, Dukes E. Conceptual adequacy of the neuropathic pain symptom inventory in six countries. Health Qual Life Outcomes 2008 ; 6 : 62.
62. Norgren L, Hiatt WR, Dormandy JA, et al. ; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007 ; 45 (Suppl) : S5-67.
63. Haute Autoritede sante(HAS). Recommandations pour la pratique clinique. Prise en charge de lartiopathie chronique oblitante athoscleuse des membres infieurs (indications micamenteuses, de revascularisation et de rducation avril 2006. www.has-sante.fr
64. Horowitz SH. The diagnostic workup of patients with neuropathic pain. Med Clin North Am 2007 ; 91 : 21-30. (Pubitemid 44880051)
65. Siebert E, Prüss H, Klingebiel R, et al. Lumbar spinal stenosis : syndrome, diagnostics and treatment. Nat Rev Neurol 2009 ; 5 : 392-403.
66. Merlino G, Valente M, Serafini A, Gigli GL. Restless legs syndrome : diagnosis, epidemiology, classification and consequences. Neurol Sci 2007 ; 28 (Suppl) : S37-46. (Pubitemid 46152127)
67. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain : 2010 revision. Eur J Neurol 2010 ; 17 : 1113-e88.
68. Argoff CE, Backonja MM, Belgrade MJ, et al. Consensus guidelines : treatment planning and options. Diabetic peripheral neuropathic pain. Mayo Clin Proc 2006 ; 81 (Suppl) : S12-25 Erratum in : Mayo Clin Proc 2006 ; 81 : 854].
69. Sindrup SH, Gram LF, Skjold T, et al. Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. Br J Clin Pharmacol 1990 ; 30 : 683-91. (Pubitemid 20377596)
70. Sindrup SH, Ejlertsen B, Frøland A, et al. Imipramine treatment in diabetic neuropathy : relief of subjective symptoms without changes in peripheral and autonomic nerve function. Eur J Clin Pharmacol 1989 ; 37 : 151-3.
71. Watson CP, Evans RJ, Reed K, et al. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982 ; 32 : 671-3. (Pubitemid 12119035)
72. Vrethem M, Boivie J, Arnqvist H, et al. A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clin J Pain 1997 ; 13 : 313-23. (Pubitemid 28028096)
73. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992 ; 326 : 1250-6.
74. Jose VM, Bhansali A, Hota D, Pandhi P. Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy. Diabet Med 2007 ; 24 : 377-83. (Pubitemid 46452398)
75. Kvinesdal B, Molin J, Froland A, Gram LF. Imipramine treatment of painful diabetic neuropathy. JAMA1984 ; 251 : 1727-30. (Pubitemid 14174179)
76. Max MB, Kishore-Kumar R, Schafer SC, et al. Efficacy of desipramine in painful diabetic neuropathy : a placebo-controlled trial. Pain 1991 ; 45 : 3-9 ; discussion 1-2.
77. Max MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987 ; 37 : 589-96. (Pubitemid 17057933)
78. Gilron I, Bailey JM, Tu D, et al. Nortriptyline and gabapentin, alone and in combination for neuropathic pain : a double-blind, randomised controlled crossover trial. Lancet 2009 ; 374 : 1252-61.
79. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2005 ; (20) : CD005454. Update in : Cochrane Database Syst Rev 2007 ; (4) : CD005454.
80. Fernstrom MH, Kupfer DJ. Antidepressantinduced weight gain : a comparison study of four medications. Psychiatry Res 1988 ; 26 : 265-71. (Pubitemid 19021045)
81. Raskin J, Pritchett YL, Wang F, et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005 ; 6 : 346-56. (Pubitemid 41727332)
82. Goldstein DJ, Lu Y, Detke MJ, et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005 ; 116 : 109-18. (Pubitemid 40828506)
83. Wernicke JF, Pritchett YL, DSouza DN, et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006 ; 67 : 1411-20. (Pubitemid 44632065)
84. Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database Syst Rev 2009 ; (4) : CD007115.
85. Gahimer J, Wernicke J, Yalcin I, et al. A retrospective pooled analysis of duloxetine safety in 23,983 subjects. Curr Med Res Opin 2007 ; 23 : 175-84. (Pubitemid 46191681)
86. Rowbotham MC, Goli V, Kunz NR, Lei D Venlafaxine extended release in the treatment of painful diabetic neuropathy : a double-blind, placebo-controlled study. Pain 2004 ; 110 : 697-706 Erratum in : Pain 2005 ; 113 : 248]. (Pubitemid 39036802)
87. Kadiroglu AK, Sit D, Kayabasi H, et al. The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus. J Diabetes Complications 2008 ; 22 : 241-5. (Pubitemid 351885487)
88. Sindrup SH, Gram LF, Brøsen K, et al. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990 ; 42 : 135-44.
89. Sindrup SH, Bjerre U, Dejgaard A, et al. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992 ; 52 : 547-52.
90. Gorson KC, Schott C, Herman R, et al. Gabapentin in the treatment of painful diabetic neuropathy : a placebo controlled, double blind, crossover trial. J Neurol Neurosurg Psychiatry 1999 ; 66 : 251-2. (Pubitemid 29103537)
91. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus : a randomized controlled trial. JAMA 1998 ; 280 : 1831-6. (Pubitemid 28544423)
92. Irving G, Jensen M, Cramer M, et al. Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia : results of a double-blind, randomized, placebo-controlled clinical trial. Clin J Pain 2009 ; 25 : 185-92.
93. Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromuscul Dis 2001 ; 3:53-62. (Pubitemid 33130299)
94. Wiffen PJ, McQuay HJ, Edwards JE, Moore RA. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2005 ; (3) : CD005452.
95. Girardin F, Desmeules JA, Piguet V, Dayer P. Utilitéde la gabapentine dans les douleurs neurogenes. Med Hyg 2003 ; 61 : 1352-7. (Pubitemid 36851803)
96. Sandercock D, Cramer M, Wu J, et al. Gabapentin extended release for the treatment of painful diabetic peripheral neuropathy : efficacy and tolerability in a double-blind, randomized, controlled clinical trial. Diabetes Care 2009 ; 32 : e20.
97. Tölle T, Freynhagen R, Versavel M, et al. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy : a randomized, doubleblind study. Eur J Pain 2007 :12 :203-13.
98. Freynhagen R, Strojek K, Griesing T, et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible-and fixed-dose regimens. Pain 2005 ; 115 : 254-63. (Pubitemid 40725282)
99. Freeman R, Durso-Decruz E, Emir B. Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy : findings from seven randomized, controlled trials across a range of doses. Diabetes Care 2008 ; 31 : 1448-54.
100. Arezzo JC, Rosenstock J, Lamoreaux L, Pauer L. Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy : a double-blind placebo-controlled trial. BMC Neurol 2008 ; 16:8-33.
101. Richter RW, Portenoy R, Sharma U, et al. Relief of painful diabetic peripheral neuropathy with pregabalin : a randomized, placebo-controlled trial. J Pain 2005 ; 6 : 253-60. (Pubitemid 40488803)
102. Moore RA, Straube S, Wiffen PJ, et al. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev 2009 ; (3) : CD007076.
103. Rull JA, Quibrera R, Gonzalez-Millan H, Lozano Castaneda O. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol) : double blind crossover trial. Diabetologia 1969 ; 5 : 215-8.
104. Rompel H, Bauermeister PW. Aetiology of migraine and prevention with carbamazepine (tegretol) : results of a double-blind, crossover study. S Afr Med J 1970 ; 44 : 75-8.
105. Eisenberg E, Lurie Y, Braker C, et al. Lamotrigine reduces painful diabetic neuropathy : a randomized, controlled study. Neurology 2001 ; 57 : 505-9. (Pubitemid 32757601)
106. Wiffen PJ, Rees J. Lamotrigine for acute and chronic pain. Cochrane Database Syst Rev 2007 ; (2) : CD006044.
107. Zhou M, He L, Yang M, et al. Oxcarbazepine for neuropathic pain (Protocol). Cochrane Database Syst Rev 2009 ; (3) : CD007963.
108. Vinik A. Clinical review : Use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy. J Clin Endocrinol Metab 2005 ; 90 : 4936-45. (Pubitemid 41159394)
109. Swerdlow M, Cundill JG. Anticonvulsivant drugs used in the treatment of lancinating pain. A comparison. Anaesthesia 1981 ; 36 : 1129-32. (Pubitemid 12203199)
110. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy : a randomized controlled trial. Neurology 2003 ; 60 : 927-34. (Pubitemid 36348923)
111. Watson CP, Moulin D, Watt-Watson J, et al. Controlled-release oxycodone relieves neuropathic pain : a randomized controlled trial in painful diabetic neuropathy. Pain 2003 ; 105 : 71-8. (Pubitemid 37162475)
112. Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin : systematic review and meta-analysis of randomized controlled trials. JAMA 2005 ; 293 : 3043-52. (Pubitemid 40965075)
113. Freeman R, Raskin P, Hewitt DJ, et al. ; CAPSS-237 Study Group. Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy. Curr Med Res Opin 2007 ; 23 : 147-61. (Pubitemid 46191680)
114. Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998 ; 50 : 1842-6. (Pubitemid 28283262)
115. Morello CM, Leckband SG, Stoner CP, et al. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999 ; 159 : 1931-7. (Pubitemid 29424714)
116. Bansal D, Bhansali A, Hota D, et al. Amitriptyline vs. pregabalin in painful diabetic neuropathy : a randomized double blind clinical trial. Diabet Med 2009 ; 26 : 1019-26.
117. Quilici S, Chancellor J, Löthgren M, et al. Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain. BMC Neurol 2009 ; 9:6.
118. Gilron I, Bailey JM, Tu D, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005 ; 352 : 1324-34. (Pubitemid 40411499)
119. Selvarajah D, Gandhi R, Emery CJ, Tesfaye S. Randomized placebo-controlled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy. Diabetes Care 2010 ; 33 : 128-30.
120. Rowbotham MC, Duan WR, Thomas J, et al. A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain. Pain 2009 ; 146 : 245-52.
121. Yuan RY, Sheu JJ, Yu JM, et al. Botulinum toxin for diabetic neuropathic pain : a randomized double-blind crossover trial. Neurology 2009 ; 72 : 1473-8.
122. Cruccu G, Aziz TZ, Garcia-Larrea L, et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol 2007 ; 14 : 952-70. (Pubitemid 47300786)
123. Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995 ; 122 : 561-8.
124. Said G, Goulon-Goeau C, Lacroix C, Moulonguet A. Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol 1994 ; 35 : 559-69. (Pubitemid 24153839)
125. Llewelyn JG, Gilbey SG, Thomas PK, et al. Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy. A clinicopathological study. Brain 1991 ; 114 : 867-92.
126. Pop-Busui R, Lu J, Lopes N, Jones TL ; BARI 2D Investigators. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. J Peripher Nerv Syst 2009 ; 14:1-13.
127. Boucek P. Advanced diabetic neuropathy : a point of no return ? Rev Diabet Stud 2006 ; 3 : 143-50.
128. Boulton AJ, Drury J, Clarke B, Ward JD. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 1982 ; 5 : 386-90. (Pubitemid 12093554)
129. Oyibo SO, Prasad YD, Jackson NJ, et al. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy : a pilot study. Diabet Med 2002 ; 19 : 870-3. (Pubitemid 35177190)
130. Muller-Felber W, Landgraf R, Scheuer R, et al. Diabetic neuropathy 3 years after successful pancreas and kidney transplantation. Diabetes 1993 ; 42 : 1482-6. (Pubitemid 23277206)
131. Comi G, Galardi G, Amadio S, et al. Neurophysiological study of the effect of combined kidney and pancreas transplantation on diabetic neuropathy : a 2-year follow-up evaluation. Diabetologia 1991 ; 34 (Suppl. 1) : S103-7.
132. Solders G, Tydén G, Persson A, Groth CG. Improvement in diabetic neuropathy 4 years after successful pancreatic and renal transplantation. Diabetologia 1991 ; 34 (Suppl. 1) : S125-7.
133. Kennedy WR, Navarro X, Goetz FC, et al. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 1990 ; 322 : 1031-7. (Pubitemid 20146661)
134. Navarro X, Sutherland DE, Kennedy WR. Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 1997 ; 42 : 727-36. (Pubitemid 27481545)
135. Derry S, Lloyd R, Moore RA, McQuay HJ. Topical capsaicin for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2009 ; (4) : CD007393.
136. Wolff RF, Bala MM, Westwood M, et al. 5% lidocaine medicated plaster in painful diabetic peripheral neuropathy (DPN): a systematic review. Swiss Med Wkly 2010 ; 140 : 297-306.
137. Farrar JT, Young JP Jr, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001 ; 94 : 149-58. (Pubitemid 33016608)